Stay updated on Nefecon in Primary IgA Nephropathy: Clinical Trial
Sign up to get notified when there's something new on the Nefecon in Primary IgA Nephropathy: Clinical Trial page.

Latest updates to the Nefecon in Primary IgA Nephropathy: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added a government operations notice and operating details (core content update) and a version bump to v3.2.0; - Removed the previous version tag v3.1.0.SummaryDifference2%
- Check17 days agoChange DetectedThe page has been updated to revision v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) as well as an older revision tag v3.0.2 have been removed.SummaryDifference0.3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check46 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as important references related to IgA glomerulonephritis and drug safety. Several previous entries have been removed, particularly related to kidney diseases and specific location terms.SummaryDifference13%
- Check60 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
Stay in the know with updates to Nefecon in Primary IgA Nephropathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nefecon in Primary IgA Nephropathy: Clinical Trial page.